KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $832.8 million.

  • BeOne Medicines' Non-Current Debt rose 34410.52% to $832.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $832.8 million, marking a year-over-year increase of 34410.52%. This contributed to the annual value of $166.5 million for FY2024, which is 1575.46% down from last year.
  • Per BeOne Medicines' latest filing, its Non-Current Debt stood at $832.8 million for Q3 2025, which was up 34410.52% from $146.1 million recorded in Q2 2025.
  • BeOne Medicines' Non-Current Debt's 5-year high stood at $832.8 million during Q3 2025, with a 5-year trough of $146.1 million in Q2 2025.
  • In the last 5 years, BeOne Medicines' Non-Current Debt had a median value of $199.0 million in 2024 and averaged $225.6 million.
  • Data for BeOne Medicines' Non-Current Debt shows a peak YoY increase of 34410.52% (in 2025) and a maximum YoY decrease of 2114.74% (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows BeOne Medicines' Non-Current Debt stood at $202.1 million in 2021, then rose by 3.48% to $209.1 million in 2022, then decreased by 5.51% to $197.6 million in 2023, then decreased by 15.75% to $166.5 million in 2024, then skyrocketed by 400.2% to $832.8 million in 2025.
  • Its Non-Current Debt stands at $832.8 million for Q3 2025, versus $146.1 million for Q2 2025 and $160.2 million for Q1 2025.